Literature DB >> 33331576

Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational study.

Tayfun Caliskan1, Bengu Saylan2.   

Abstract

OBJECTIVE: We aimed to explore the prevalence of smoking rates and comorbidities and evaluate the relationship between them and disease severity and mortality in inpatients with COVID-19.
METHODS: COVID-19 patients were divided into the following groups: clinic group, intensive care unit (ICU) group, survivors, and non-survivors. Non-COVID-19 patients were included as a control group. The groups were compared.
RESULTS: There was no difference between patients with and without COVID-19 in terms of smoking, asthma, diabetes, dementia, coronary artery disease (CAD), hypertension, chronic renal failure and arrhythmia (p>0.05). Older age (Odds ratio (OR), 1.061; 95% confidence interval (CI): 1.041-1.082; p< 0.0001), chronic obstructive pulmonary disease (COPD) (OR, 2.775; 95% CI: 1.128-6.829; p=0.026) and CAD (OR, 2.696; 95% CI: 1.216-5.974; p=0.015) were significantly associated with ICU admission. Current smoking (OR, 5.101; 95% CI: 2.382-10.927; p<0.0001) and former smoking (OR, 3.789; 95% CI: 1.845-7.780; p<0.0001) were risk factors for ICU admission. Older age (OR; 1.082; 95% CI: 1.056-1.109; p<0.0001), COPD (OR, 3.213; 95% CI: 1.224-8.431; p=0.018), CAD (OR, 6.252; 95% CI: 2.171-18.004; p=0.001) and congestive heart failure (CHF) (OR, 5.917; 95% CI 1.069-32.258; p=0.042), were significantly associated with mortality. Current smoking (OR, 13.014; 95% CI: 5.058-33.480; p<0.0001) and former smoking (OR, 6.507; 95% CI 2.731-15.501; p<0.0001) were also risk factors for mortality.
CONCLUSION: Smoking, older age, COPD, and CAD were risk factors for ICU admission and mortality in patients with COVID-19. CHF was not a risk factor for ICU admission; however, it was a risk factor for mortality.

Entities:  

Year:  2020        PMID: 33331576     DOI: 10.1590/1806-9282.66.12.1679

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  9 in total

1.  Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action.

Authors:  Lin Liu; Shu-Yu Ni; Wei Yan; Qing-Dong Lu; Yi-Miao Zhao; Ying-Ying Xu; Huan Mei; Le Shi; Kai Yuan; Ying Han; Jia-Hui Deng; Yan-Kun Sun; Shi-Qiu Meng; Zheng-Dong Jiang; Na Zeng; Jian-Yu Que; Yong-Bo Zheng; Bei-Ni Yang; Yi-Miao Gong; Arun V Ravindran; Thomas Kosten; Yun Kwok Wing; Xiang-Dong Tang; Jun-Liang Yuan; Ping Wu; Jie Shi; Yan-Ping Bao; Lin Lu
Journal:  EClinicalMedicine       Date:  2021-09-08

Review 2.  Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Abraham Degarege; Zaeema Naveed; Josiane Kabayundo; David Brett-Major
Journal:  Pathogens       Date:  2022-05-10

3.  Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease.

Authors:  Paul D Terry; R Eric Heidel; Rajiv Dhand
Journal:  Am J Respir Crit Care Med       Date:  2021-04-01       Impact factor: 21.405

4.  The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.

Authors:  Nurdan Kokturk; Cenk Babayigit; Seval Kul; Pelin Duru Cetinkaya; Sibel Atis Nayci; Serap Argun Baris; Oguz Karcioglu; Pinar Aysert; Ilim Irmak; Aycan Akbas Yuksel; Yonca Sekibag; Oya Baydar Toprak; Emel Azak; Sait Mulamahmutoglu; Caglar Cuhadaroglu; Aslihan Demirel; Bugra Kerget; Burcu Baran Ketencioglu; Hasan Selcuk Ozger; Gulcihan Ozkan; Zeynep Ture; Begum Ergan; Vildan Avkan Oguz; Oguz Kilinc; Merve Ercelik; Tansu Ulukavak Ciftci; Ozlem Alici; Esra Nurlu Temel; Ozlem Ataoglu; Asena Aydin; Dilek Cetiner Bahcetepe; Yusuf Taha Gullu; Fusun Fakili; Figen Deveci; Neslihan Kose; Muge Meltem Tor; Gulsah Gunluoglu; Sedat Altin; Teyfik Turgut; Tibel Tuna; Onder Ozturk; Oner Dikensoy; Pinar Yildiz Gulhan; Ilknur Basyigit; Hasim Boyaci; I Kivilcim Oguzulgen; Sermin Borekci; Bilun Gemicioglu; Firat Bayraktar; Osman Elbek; Ismail Hanta; Hacer Kuzu Okur; Gulseren Sagcan; Oguz Uzun; Metin Akgun; Goksel Altinisik; Berna Dursun; Ebru Cakir Edis; Erkmen Gulhan; Fusun Oner Eyuboglu; Okkes Gultekin; Yavuz Havlucu; Metin Ozkan; Aysin Sakar Coskun; Abdullah Sayiner; Ali Fuat Kalyoncu; Oya Itil; Hasan Bayram
Journal:  Respir Med       Date:  2021-04-28       Impact factor: 3.415

5.  Development and validation of the CoV19-OM intensive care unit score: An early ICU identification for laboratory-confirmed SARS-CoV-2 patients from a retrospective cohort study in Oman.

Authors:  Eduardo M Lacap; Abraham Varghese; Faryal Khamis; Maher Al Bahrani; Hamed Al Naamani; Shajidmon Kolamban; Samata Al Dowaiki; Huda Salim Al Shuaily
Journal:  Int J Infect Dis       Date:  2021-04-24       Impact factor: 12.074

6.  Asthma and COVID-19 risk: a systematic review and meta-analysis.

Authors:  Anthony P Sunjaya; Sabine M Allida; Gian Luca Di Tanna; Christine R Jenkins
Journal:  Eur Respir J       Date:  2022-03-31       Impact factor: 16.671

7.  Expression of SARS-CoV-2 Entry Factors in Human Alveolar Type II Cells in Aging and Emphysema.

Authors:  Chih-Ru Lin; Karim Bahmed; Hannah Simborio; Hassan Hayek; Sudhir Bolla; Nathaniel Marchetti; Gerard J Criner; Beata Kosmider
Journal:  Biomedicines       Date:  2021-07-06

8.  Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study.

Authors:  Kona Chowdhury; Mainul Haque; Nadia Nusrat; Nihad Adnan; Salequl Islam; Afzalunnessa Binte Lutfor; Dilara Begum; Arif Rabbany; Enamul Karim; Abdul Malek; Nasim Jahan; Jesmine Akter; Sumala Ashraf; Mohammad Nazmul Hasan; Mahmuda Hassan; Najnin Akhter; Monika Mazumder; Nazmus Sihan; Nurun Naher; Shaheen Akter; Sifat Uz Zaman; Tanjina Chowdhury; Jebun Nesa; Susmita Biswas; Mohammod Didarul Islam; Al Mamun Hossain; Habibur Rahman; Palash Kumar Biswas; Mohammed Shaheen; Farah Chowdhury; Santosh Kumar; Amanj Kurdi; Zia Ul Mustafa; Natalie Schellack; Marshall Gowere; Johanna C Meyer; Sylvia Opanga; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-01-14

9.  Clinical characteristics and treatment outcomes of severe (ICU) COVID-19 patients in Saudi Arabia: A single centre study.

Authors:  Saleh Alghamdi
Journal:  Saudi Pharm J       Date:  2021-08-04       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.